Press Release: OIG Senior Counsel Mary Riordan Keynotes National Disclosure Summit
- A Hybrid Conference, Internet Event and Training Tool
- March 5 - 6, 2009
- Onsite at the Renaissance Washington DC Hotel, Washington, DC
- Online In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
- www.DisclosureSummit.com
PRESS RELEASE
Phone: 800-684-4549
Email: registration@hcconferences.com
Website: www.DisclosureSummit.com
|
|
SUMMIT GRANTORS
|
|
GOLD
|
|
|
SILVER
|
|
|
|
BRONZE
|
|
|
PHARMA AND DEVICE DISCLOSURE UPDATES
|
- Click here for Mass. Unveils Draft Rules on Gifts from Drug, Device Makers
- Click here for Activists Blast Draft of Disclosure Rules in Mass.
- Click here for Penn Medicine to Disclose Doctors' Drug Ties
- Click here for more -
|
DISCLOSURE TRAINING PROGRAM
|
|
|
EARLY BIRD REGISTRATION DISCOUNT
|
Register by Wednesday, January 30, 2008
for Early Bird $200 discount.
Click here to register. |
|
FEATURING
|
PRECONFERENCE: DISCLOSURE BOOT CAMP
Understanding the Forces Driving Disclosure: State Legislators, MedPAC, US Congress: The Sunshine Act, State Enforcers, OIG, Settlements and CIAs
Introduction to Existing State Disclosure Laws and Regulations: Massachusetts, Minnesota, Nevada, Vermont, Washington, DC and West Virginia
Aggregate Spend 101: The Nuts and Bolts of an Aggregate Spend Program
DAY I: THE PERFECT STORM: DISCLOSURE GRIPS THE DRUG AND DEVICE INDUSTRIES
The Physician Payments Sunshine Act: Prospects for Federal Disclosure Law
MedPAC may Reshape the Disclosure Agenda for Congress
The Role of the States
The Role of the OIG
The Role of Prosecutions, Settlements and CIAs
A Dialogue on Whether Disclosure Will Quiet the Industry's Critics?
What to Expect From the New Congress and the New Administration
|
Key Congressional Initiatives
What to Expect from the New Administration
DTC: The Perennial Target
CME: Under Fire from all Directions
|
DAY II: HOW TO ESTABLISH EFFECTIVE DISCLOSURE PROTOCOLS AND AGGREGATE SPEND PROGRAMS
Lessons of the Deferred Prosecution Agreements in the Device Sector
Enforcement Panel: State and Federal Prosecutors Assess Disclosure as a Compliance Tool
Case Study: Implementation of Eli Lilly's Physician Payment Disclosure Initiative
Analysis of Industry Aggregate Spend Survey Results: A Gap Assessment
Case Study: How to Build an Aggregate Spend Program at a Small or Mid-Size Company
Case Study: Planning Aggregate Spend Activities for the Next Three Years
State Regulatory Panel: Evolving State Laws and Regulations
Evolving Practices in Aggregate Spend: What Does the Future Hold?
Industry Disclosure Best Practice Roundtable
|
SPECIAL PRESENTATION ON DISCLOSURE
AT 2008 PHARMA CONGRESS
|
Click here for Video of OIG's Mary Riordan on Disclosure at PCF Ninth Pharma Congress, October 27, 2008
|
|
|
WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- JANUARY 5, 2009: The National Disclosure Summit, www.DisclosureSummit.com, March 5 - 6, 2009, will be held at the Renaissance Washington DC Hotel in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).
Those registrants who desire to take a deeper dive into the subject matter of the conference may participate in the Disclosure Summit Training Program which includes preconference readings, completion of an online course on Disclosure prepared by Arnold & Porter and Huron Consulting, attendance at the Summit preconference boot camp and Summit and successful completion of a post conference online examination.
By arranging to license online group access to the Summit Disclosure Summit Training Program, pharmaceutical, device and biotech companies subject to disclosure and aggregate spend requirements can implement company-wide online training programs. The company training coordinator can assign and track online participation. Successful completion of the training can be evidenced by passing the post conference training examination.
FIRST ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND
AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
A Pharma Congress Conference
March 5 - 6, 2009
|
ONSITE
Renaissance Washington DC Hotel
Washington, DC
|
OR |
ONLINE
In your own office or home live via the Internet
with 24/7 access for six months
|
 |
|
|
| OIG SENIOR COUNSEL MARY RIORDAN TO GIVE KEYNOTE ADDRESS |
The Summit's keynote address will be given by OIG Senior Counsel Mary E. Riordan, Esq. on The Role of the OIG in Pharmaceutical and Device Disclosure and Transparency:
|
Mary E. Riordan, Esq., Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DCSenator |
|
|
FEATURED FACULTY
|
| LEADING FEDERAL AND STATE POLICYMAKERS |
|
|
 |
Christopher J. Armstrong, Esq., Investigative Counsel, Committee on Finance, The Honorable Chuck Grassley, Ranking Member, United States Senate, Washington, DC |
 |
David A. Catania, Esq., Member and Chair, Committee on Health, City Council, Washington, DC |
 |
Senator Charles Grassley (R-IA), Ranking Member, Senate Finance Committee, United States Senate, Washington, DC |
|
|
|
|
 |
Mark C. Montigny, Massachusetts State Senate, New Bedford, MA
|
 |
Sharon Anglin Treat, Esq., Maine State Representative, Chair, NLARx, Augusta, ME |
|
|
|
| LEADING FEDERAL AND STATE PROSECUTORS |
 |
Julie Brill, Esq., Assistant Attorney General, State of Vermont, Montpelier, VT |
 |
Michele Brown, Esq., Counsel to the United States Attorney, US Attorney for the District of New Jersey, Newark, NJ |
 |
Christopher J. Christie, Esq., Former United States Attorney for the District of New Jersey, Newark, NJ
|
 |
David Hart, Esq., Assistant Attorney General, Oregon Department of Justice, Salem, OR |
|
|
 |
Daniel R. Miller, Esq., Deputy Attorney General, Director, Medicaid Fraud Control Unit, Delaware Department of Justice, President, NAMFCU, Wilmington, DE |
|
Mary E. Riordan, Esq., Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
|
 |
James G. Sheehan, Esq., New York State Medicaid, Inspector General, Former Associate United States Attorney, US Attorney's Office, Eastern District of Pennsylvania, Albany, NY |
|
|
|
| LEADING COMPLIANCE PROFESSIONALS |
 |
Michael Bigelow, Esq., Assistant General Counsel, Eli Lilly and Company, Indianapolis, IN |
 |
Kathy Bronshtein, Director Healthcare Law Compliance, Pharmaceuticals, Alpharma Pharmaceuticals, LLC, Bridgewater, NJ |
 |
Cynthia Cetani, Executive Director, Ethics & Compliance, Novartis Pharmaceuticals, Suffern, NY |
 |
Margaret Feltz, Associate Director, Corporate Compliance, Purdue Pharma LP, Stamford, CT |
|
|
 |
Geralyn S. Ritter, Vice-President, Global Public Policy and Corporate Responsibility, Merck & Co., Inc., Indianapolis, ID |
 |
Michael Varlotta, Senior Director, Department of Medical Education, Medical Affairs, Centocor, a wholly owned subsidiary of Johnson & Johnson, Horsham, PA |
|
|
|
| LEADING ACADEMICS AND POLICY EXPERTS |
|
|
 |
Allan Coukell, Director of Policy, Prescription Project, Winner, 2007 Edward R. Murrow Award, Boston, MA |
 |
Peter Lurie, MD, MPH, Deputy Director, Public Citizen's Health Research Group, Washington, DC |
 |
David J. Rothman, PhD, Bernard Schoenberg Professor of Social Medicine, Columbia College of Physicians & Surgeons, and Professor of History, Columbia University, President, IMAP, New York, NY |
|
|
|
| LEADING ADVISORS AND LEGAL COUNSEL |
 |
John T. Bentivoglio, Esq., Partner, King & Spalding LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, Department of Justice, Washington, DC |
 |
Jeff Brady, MBA, President, Advanced Health Media LLC, Bridgewater, NJ |
 |
James H. Davidson, Esq., Shareholder, Davidson & Company and Polsinelli Shalton Welte Suelthaus, PC, Washington, DC |
 |
John P. Ford, Esq., Counsel, Sidley Austin, Former Senior Democratic Counsel, Energy and Commerce Committee, US House of representatives, Washington, DC |
 |
Wendy C. Goldstein, Esq., Partner and Chairperson, Pharmaceutical Industry Health Regulatory Practice Group, Epstein Becker & Green, New York, NY |
 |
John F. Kamp, JD, PhD, Executive Director, Coalition for Healthcare Communication, Of Counsel, Wiley Rein, Washington, DC |
 |
Daniel A. Kracov, Esq., Partner, Arnold & Porter, Washington, DC |
 |
Joshua S. Levy, Esq., Partner, Ropes & Gray, Former Assistant United States Attorney, District of Massachusetts, Boston, MA |
 |
Kathleen Meriwether, Esq., Principal, Fraud Investigation & Dispute Services, Ernst & Young, Former Assistant United States Attorney, Eastern District of Pennsylvania, Department of Justice, Philadelphia, PA |
 |
Peter Pitts, Director, Center for Medicines in the Public Interest (CAMPY), Senior Vice President for Health Affairs, Manning, Selvage & Lee, Washington, DC |
 |
Brian Riewerts, Partner, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP, Washington, DC |
 |
William A. Sarraille, Esq., Partner, Sidley Austin Brown & Wood, Washington, DC |
 |
Paul J. Silver, Managing Director, Huron Consulting Group, LLC, Atlanta, GA |
 |
Craig H. Smith, Esq., Partner, Hogan & Hartson LLP, Former General Counsel, Florida Agency for Health Care Administration, Washington, DC |
 |
Thomas Sullivan, President and Founder, Rockpointe Corporation, Washington, DC |
 |
Jon Wilkenfeld, President, Potomac River Partners, Vienna, VA |
|
|
|
|
THE TIME IS NOW FOR NEW, EFFICIENT AND COST EFFECTIVE ALTERNATIVES TO TRADITIONAL LEARNING APPROACHES
|
|
A variety of forces - the nation's economic crisis, costly and difficult air travel, the mandate for cost efficiency in healthcare, the proliferation of greater Internet bandwidth, the emergence of the popularity of online video via You Tube, and the explosion of online training in the health sector - has come together to create both a dramatic need and an extraordinary opportunity for innovative approaches to sharing new ideas and best practices. This Summit offers not only traditional conference attendance, but also to opportunity to attend the event live and archived online.
How can we be expected to reform the nation's health system if we can not reform the way we do our own business?
|
|
CONTENT OPTIONS
|
TRADITIONAL CONFERENCE REGISTRATION
Register for Preconference Disclosure Summit Boot Camp and/or Conference.
DISCLOSURE TRAINING PROGRAM
The Disclosure Summit is offering a Disclosure Training Program in the form of an optional course within the conference for attendees wishing to take a deeper dive into the Summit's subject matter. The Program requirements are:
- Completion of preconference readings
- Completion of an online course on Disclosure prepared by Arnold & Porter and Huron Consulting
- Consideration of a series of preconference questions
- Attend Preconference Disclosure Summit Boot Camp either in person or online
- Attend Summit either in person or online
- Successfully complete of a post-conference online examination
Attendees who successfully complete Program requirements will receive a certificate of completion.
|
|
|
|
PARTICIPATION OPTIONS
|
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; facility interaction
LIVE AND ARCHIVED INTERNET ATTENDANCE
Watch the conference in live streaming video over the Internet and at your convenience
at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away for the office |
|
INTERNET INTERFACE SAMPLE
|
Click here for a sample stream
|
|
|
|
|
THE GROUP REGISTRATION/ONLINE TRAINING ALTERNATIVE
|
|
By arranging to license online group access to the Summit Disclosure Summit Training Program, pharmaceutical, device and biotech companies subject to disclosure and aggregate spend requirements can implement company-wide online training programs. The company training coordinator can assign and track online participation. Successful completion of the training can be evidenced by passing the post conference training examination.
|
|
HERE IS AN EXAMPLE OF A PHARMA COMPANY DISCLOSURE TRAINING PROGRAM
|
|
|
|
|
SAVE THE DATE
|
FIRST ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
A Hybrid Conference, Internet Event and Training Tool
March 5 - 6, 2009
Renaissance Washington DC Hotel
Washington, DC
www.DisclosureSummit.com
|
|
THIRD INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
May 28 - 29, 2009
Rome, Italy
www.InternationalPharmaCongress.com
|
|
FOURTH ANNUAL MEDICAL DEVICE REGULATORY, REIMBURSEMENT AND COMPLIANCE CONGRESS
November 9 - 11, 2009
JW Marriott Hotel
Washington, DC
www.DeviceCongress.com
|
|
TENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
November 11 - 13, 2009
JW Marriott Hotel
Washington, DC
www.PharmaCongress.com
|
|
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
|
For changes or additions, please email your request to: listmgr@HealthCareUpdateNewsService.com.
For removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below to automatically remove your address from the list.
|
|
|
|
